Skip to main content
. Author manuscript; available in PMC: 2014 Sep 12.
Published in final edited form as: Neonatology. 2013 Sep 12;104(3):10.1159/000353721. doi: 10.1159/000353721

Figure 4. Phase 2 validation study: Western blot.

Figure 4

IL-1RA within 2 to 3 weeks before NEC (A) and Alpha-1 antitrypsin 1 week before NEC (B) were decreased in cases compared to control (P=0.08, n=10 and P=0.06, n=8; respectively). Peroxiredoxin 1 week before NEC (C) was not promising (P=0.48, n=6).